Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Myelination of axons by oligodendrocytes enables rapid impulse propagation in the central nervous system. But long-term interactions between axons and their myelin sheaths are poorly understood. Here we show that Cnp1, which encodes 2',3'-cyclic nucleotide phosphodiesterase in oligodendrocytes, is essential for axonal survival but not for myelin assembly. In the absence of glial cyclic nucleotide phosphodiesterase, mice developed axonal swellings and neurodegeneration throughout the brain, leading to hydrocephalus and premature death. But, in contrast to previously studied myelin mutants, the ultrastructure, periodicity and physical stability of myelin were not altered in these mice. Genetically, the chief function of glia in supporting axonal integrity can thus be completely uncoupled from its function in maintaining compact myelin. Oligodendrocyte dysfunction, such as that in multiple sclerosis lesions, may suffice to cause secondary axonal loss.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A direct role for oligodendrocytes to sustain axonal function is supported by the observation that mice lacking 2′,3′-cyclic nucleotide phosphodiesterase (CNPase) or proteolipid protein (PLP) display axonal dysfunction without demyelination in the spinal cord and brain [86,87].”
From X-linked adrenoleukodystrophy: Clinical, metabolic, genetic and pathophysiological aspects (2012) · cites this paper as [87]
Citations
Cites
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
MYELINATION IN RAT BRAIN: METHOD OF MYELIN ISOLATION1
Norton, W. T., & Poduslo, S. E. (1973) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1973.tb07519.x · Cited by 1,413
Silver Staining of Myelin by Means of Physical Development
Gallyas, F. (1979) · Neurological Research · doi:10.1080/01616412.1979.11739553 · Cited by 935
Axonal Swellings and Degeneration in Mice Lacking the Major Proteolipid of Myelin
Griffiths, I., Klugmann, M., Anderson, T., Yool, D., Thomson, C., Schwab, M. H., Schneider, A., Zimmermann, F., McCulloch, M., Nadon, N., et al. (1998) · Science · doi:10.1126/science.280.5369.1610 · Cited by 889
Self-citationRd, H. (1948) · PubMed · Cited by 872
CNS Myelin and Sertoli Cell Tight Junction Strands Are Absent in Osp/Claudin-11 Null Mice
Gow, A., Southwood, C. M., Li, J. S., Pariali, M., Riordan, G. P., Brodie, S. E., Danias, J., Bronstein, J. M., Kachar, B., & Lazzarini, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)81553-6 · Cited by 699
Gene Targeting: A Practical Approach
Hirst, M. (1994) · Journal of Medical Genetics · doi:10.1136/jmg.31.10.821-a · Cited by 585
Gene targeting: a practical approach.
Joyner, A. L. (1993) · Cited by 575
Giese, K. P., Martini, R., Lemke, G., Soriano, P., & Schachner, M. (1992) · Cell · doi:10.1016/0092-8674(92)90591-y · Cited by 502
Assembly of CNS Myelin in the Absence of Proteolipid Protein
Klugmann, M., Schwab, M. H., Pühlhofer, A., Schneider, A., Zimmermann, F., Griffiths, I. R., & Nave, K.-A. (1997) · Neuron · doi:10.1016/s0896-6273(01)80046-5 · Cited by 471
Self-citation
Cited by
Items 501–600 of 1,000
Lei, Z., Yue, Y., Stone, S., Wu, S., & Lin, W. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1156-20.2020 · Cited by 37
“Genotypes of mice were determined by PCR from DNA extracted from tail tips as described previously (Zhang et al., 2002; Lappe-Siefke et al., 2003; Sasaki et al., 2006).”
BackgroundMethodInfluentialDefective Oligodendroglial Lineage and Demyelination in Amyotrophic Lateral Sclerosis
Traiffort, É., Morisset‐Lopez, S., Moussaed, M., & Zahaf, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073426 · Cited by 37
“In agreement with this observation, CNP knockout mice display axonal degeneration in myelinated fibers despite the presence of functional myelin whereas MBP knockout mice exhibit no axonal loss despite absence of myelination [61,63].”
BackgroundKhalaf, G., Mattern, C., Bégou, M., Boespflug‐Tanguy, O., Massaad, C., & Massaad-Massade, L. (2022) · Biomedicines · doi:10.3390/biomedicines10071709 · Cited by 39
“Thus, any disruption or dysregulation of the oligodendrocytes will have repercussions on the myelin and subsequently on the axons and the entire white matter [4].”
BackgroundMaki, T., Takahashi, Y., Miyamoto, N., Liang, A. C., Ihara, M., Lo, E. H., & Arai, K. (2015) · Stem Cell Research · doi:10.1016/j.scr.2015.05.001 · Cited by 35
“Mouse models of oligodendrocyte injury, such as proteolipid protein (plp1)-null mice or Cnp mutant mice, show axon loss without considerable demyelination [10, 11], suggesting that oligodendrocytes may also support axon survival through a myelin-independent mechanisms [12].”
BackgroundRadja, F., Kay, D. G., Albrecht, S., & Jolicoeur, P. (2003) · Journal of Virology · doi:10.1128/jvi.77.21.11745-11753.2003 · Cited by 35
“A recent report on the CNPase-encoding gene (cnp1) indeed shows that in Cnp-1-deficient mice, axonal loss and neurodegeneration occur throughout the brain as a consequence of the dysfunction of oligodendrocytes but in the absence of apparent myelin changes (27, 38).”
BackgroundWang, S. J., Furusho, M., D'Sa, C., Kuwada, S., Conti, L., Morest, D. K., & Bansal, R. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22164 · Cited by 34
“Specifically, oligodendrocytes of transgenic mice with deletion of myelin proteins CNP or PLP remain viable and make compact myelin but develop late-onset axonal degeneration (Griffiths et al., 1998; Lappe-Siefke et al., 2003).”
BackgroundLisowski, P., Juszczak, G. R., Gościk, J., Wieczorek, M., Zwierzchowski, L., & Swiergiel, A. H. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.08.004 · Cited by 35
Ip, C. W., Kroner, A., Groh, J., Huber, M., Klein, D., Spahn, I., Diem, R., Williams, S. K., Nave, K.-A., Edgar, J. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042554 · Cited by 33
“Other studies in the central nervous system on mice deficient in PLP or 29, 39 -cyclic nucleotide 39-phosphodiesterase also showed that mutant myelinating cells impair retrograde axonal transport [2] or cause features indicative of defective axonal transport [3], revealing a tight link beween the molecular integrity o…”
BackgroundSelf-citationZhao, Y., Shi, X., Qiu, X., Zhang4, L., Wei, W., Shu, Li, C., Cheng, G., Yang, Z., & Tang, Y. (2011) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2011-1854 · Cited by 38
“With age, however, the efficiency of this remyelination declined or was lost completely (Nave 2003).”
BackgroundChen, X., Wang, F., Gan, J., Zhang, Z., Liang, X., Li, T., Huang, N., Zhao, X., Mei, F., & Xiao, L. (2020) · Neuroscience Bulletin · doi:10.1007/s12264-019-00449-7 · Cited by 33
“Olig2-flox mice and CNP-Cre mice were as previously described [22, 23].”
Slowly Progressive Axonal Degeneration in a Rat Model of Chronic, Nonimmune-Mediated Demyelination
Wilkins, A., Kondo, Y., Song, J. C., Liu, S., Compston, A., Black, J. A., Waxman, S. G., & Duncan, I. D. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181ffc317 · Cited by 36
“For example, mice lacking 2¶,3¶-cyclic nucleotide phosphodiesterase, a relatively minor component of myelin, have morphologically normal myelin, but show delayed axonal swelling and degeneration (13).”
BackgroundLin, C.-Y., Sawa, A., & Jaaro-Peled, H. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.08.025 · Cited by 37
Purines: forgotten mediators in traumatic brain injury
Jackson, E. K., Boison, D., Schwarzschild, M. A., & Kochanek, P. M. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13551 · Cited by 34
“Studies by Lappe-Siefke et al. (2003)suggested that myelin and axonal morphology are normal in CNPase / mice up to about 3.5 months of age.”
BackgroundInfluentialAcetyl‐CoA production from pyruvate is not necessary for preservation of myelin
Nunes, G. D., Mueller, L. E., Silvestri, N. J., Patel, M. S., Wrabetz, L. G., Feltri, M. L., & Poitelon, Y. (2017) · Glia · doi:10.1002/glia.23184 · Cited by 35
“We expected that ablation of PDC in myelinating cells, presumably reducing the pool of available acetyl-CoA, would drastically affect the functions and survival of OLs and SCs. Acetyl-CoA is a central molecule of metabolism, representing the starting point of the TCA cycle and being a key precursor for fatty acids.”
BackgroundMethodInfluentialWu, S., Stone, S., Nave, K., & Lin, W. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.0604-20.2020 · Cited by 35
“Genotypes were determined by PCR from DNA extracted from tail tips as described previously (Klugmann et al., 1997; Zhang et al., 2002; Lappe-Siefke et al., 2003; Sun et al., 2014).”
BackgroundMethodSelf-citationCellular senescence and failure of myelin repair in multiple sclerosis
Koutsoudaki, P. N., Papadopoulos, D., Passias, P.-G., Koutsoudaki, P., & Gorgoulis, V. G. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111366 · Cited by 33
The EGR2 gene is involved in axonal Charcot−Marie−Tooth disease
Sevilla, T., Sivera, R., Martínez‐Rubio, D., Lupo, V., Chumillas, M. J., Calpena, E., Dopazo, J., Vilchez, J. J., Palau, F., & Espinós, C. (2015) · European Journal of Neurology · doi:10.1111/ene.12782 · Cited by 33
“A similar physiopathological process can be observed in certain mouse models with deficient myelin or glial proteins, such as myelin associated glycoprotein or 2,3-cyclic nucleotide phosphodiesterase, which develop axonal degeneration with preserved myelin [23,24].”
BackgroundViader, A., Wright-Jin, E. C., Vohra, B. P. S., Heuckeroth, R. O., & Milbrandt, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027727 · Cited by 34
“Matings of transgenic animals Tfam mice [19] and CNP-Cre mice [26] in pure C57Bl/ 6 backgrounds were crossed to generate Tfam-ENSKO mice (CNP-Cre, Tfam) and their control littermates (CNP-Cre, Tfam or CNP-Cre, Tfam).”
MethodVerden, D. R., & Macklin, W. B. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23923 · Cited by 36
“…saltatory conduction, oligodendrocytes have been implicated in other crucial CNS functions, such as maintaining ion homeostasis (Menichella et al., 2006) and providing trophic/metabolic support to axons (Griffiths et al., 1998; Lappe-Siefke et al., 2003, reviewed in Morrison et al., 2013).”
BackgroundNatalia Silva, P., Furuya, T. K., Sampaio Braga, I., Rasmussen, L. T., de Labio, R. W., Bertolucci, P. H., Chen, E. S., Turecki, G., Mechawar, N., Payão, S. L., et al. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-121192 · Cited by 30
Gender differences in the histopathology of MS?
Kuhlmann, T., GOLDSCHMIDT, T. J., Antel, J. P., Wegner, C., König, F. B., Metz, I., & Brück, W. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.07.014 · Cited by 38
Saifetiarova, J., Taylor, A. M., & Bhat, M. A. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.2661-16.2017 · Cited by 33
“Furthermore, the disrupted nodal cytoskeleton potentially contributes to altered axonal transport and ultimately to axonal pathology (Ballin and Thomas, 1969; Lappe-Siefke et al., 2003; Garcia-Fresco et al., 2006; Fabrizi et al., 2007).”
BackgroundA predominantly glial origin of axonal ribosomes after nerve injury
Müller, K., Schnatz, A., Schillner, M., Wörtge, S., Müller, C., von Graevenitz, I., Waisman, A., van Minnen, J., & Vogelaar, C. F. (2018) · Glia · doi:10.1002/glia.23327 · Cited by 32
“, 2011) were purchased from the Emma mouse repository and CNP Cre mice (Kaga et al., 2006; Lappe-Siefke et al., 2003) were obtained from Klaus-Armin Nave (MPI for Experimental Medicine G€ ottingen).”
MethodRobinson, R. R., Dietz, A. K., Maroof, A. M., Asmis, R., & Forsthuber, T. G. (2019) · Immunotherapy · doi:10.2217/imt-2018-0153 · Cited by 33
Yang, F. C., Guan, Y., Feng, X. M., Rolfs, A., Schlüter, H., & Luo, J. (2019) · Molecular Brain · doi:10.1186/s13041-019-0440-9 · Cited by 33
Rivellini, C., Porrello, E., Dina, G., Mrakic-Sposta, S., Vezzoli, A., Bacigaluppi, M., Gullotta, G. S., Chaabane, L., Leocani, L., Marenna, S., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145071 · Cited by 33
“Predominant microglia activation is a common finding in both primary progressive MS and leukodystrophies (3, 39, 45, 46), and is observed in other models featuring oligodendrocyte dysfunction (10, 18).”
BackgroundSelf-citationRemodeling of motor nerve terminals in demyelinating axons of periaxin‐null mice
Court, F. A., Brophy, P., & Ribchester, R. R. (2008) · Glia · doi:10.1002/glia.20620 · Cited by 33
“One candidate for this inhibitory effect on axonal sprouting is the myelin associated glycoprotein (MAG), which has been shown to inhibit both axonal regeneration and sprouting in the peripheral and central nervous system (PNS and CNS, respectively) (Li et al., 1996; McKerracher et al., 1994; Shen et al., 1998; Wong e…”
BackgroundInfluentialKolaric, K. V., Thomson, G., Edgar, J. M., & Brown, A. M. (2013) · Physiological Reports · doi:10.1002/phy2.59 · Cited by 32
“Primers for identification of Cnp1 alleles were described previously (Lappe-Siefke et al. 2003).”
MethodDifferential RIP antigen (CNPase) expression in peripheral ensheathing glia
Toma, J. S., McPhail, L. T., & Ramer, M. S. (2006) · Brain Research · doi:10.1016/j.brainres.2006.12.053 · Cited by 32
Martins‐Macedo, J., Lepore, A. C., Domingues, H. S., Salgado, A. J., Gomes, E. D., & Pinto, L. (2020) · Glia · doi:10.1002/glia.23922 · Cited by 38
A Role for Hemopexin in Oligodendrocyte Differentiation and Myelin Formation
Morello, N., Bianchi, F. T., Marmiroli, P., Tonoli, E., Menendez, V. R., Silengo, L., Cavaletti, G., Vercelli, A., Altruda, F., & Tolosano, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020173 · Cited by 33
“function and maintenance of axons [9] and, on the other hand,”
BackgroundInfluence of neurosteroids on the pathogenesis of multiple sclerosis
Leitner, H. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.02.028 · Cited by 33
“Reduction of the myelin protein CNP causes axonal degeneration in a mouse model [39].”
BackgroundChatonnet, F., Guyot, R., Picou, F., Bondesson, M., & Flamant, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030703 · Cited by 32
“Cell specific recombinations were obtained by crossing TRaAMI mice with OtxCRE-ERT2 [44], Ptf1aCRE [45], CnpCRE [46].”
MethodEpigenetic Modulation of Human Induced Pluripotent Stem Cell Differentiation to Oligodendrocytes
Douvaras, P., Rusielewicz, T., Kim, K., Haines, J. D., Casaccia, P., & Fossati, V. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040614 · Cited by 32
“, convulsions, gait abnormalities, weakness) and ultimately precocious death [9].”
BackgroundGenetic Analysis of Anterior-Posterior Expression Gradients in the Developing Mammalian Forebrain
Kudo, L. C., Karsten, S. L., Chen, J., Levitt, P., & Geschwind, D. H. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhl118 · Cited by 31
“2000) Cnp1 Hydrocephalus and neurodegeneration (Lappe-Siefke et al. 2003) Sfrp1 Decreased brain size (Bodine et al.”
BackgroundChen, X., Zhang, W., Li, T., Guo, Y., Tian, Y., Wang, F., Liu, S., Shen, H., Feng, Y., & Xiao, L. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00467 · Cited by 31
“The mice that express Cre recombinase under the control of the CNPase ( CNP ) promoter ( CNP-Cre mice) were also previously described (Lappe-Siefke et al., 2003) where Cre recombinase was knocked into one allele of the CNP gene locus.”
BackgroundGould, R. M., Morrison, H. G., Gilland, E., & Campbell, R. K. (2005) · Biological Bulletin · doi:10.2307/3593141 · Cited by 30
“Mutants lacking all other myelin proteins—including PLP, MAL, and 2 , 3 -cyclic nucleotide 3 -phosphodiesterase (CNP)—make relatively normal myelin before instability, axon degeneration, or both set in (Boison and Stoffel, 1994; Lappe-Siefke et al., 2003; Schaeren-Wiemers et al., 2004).”
BackgroundBan, M., McCauley, J. L., Zuvich, R. L., Baker, A., Bergamaschi, L., Cox, M., Kemppinen, A., D’Alfonso, S., Guerini, F. R., Lechner‐Scott, J., et al. (2010) · Genes and Immunity · doi:10.1038/gene.2010.36 · Cited by 34
Akiyama, M., Hasegawa, H., Hongu, T., Frohman, M. A., Harada, A., Sakagami, H., & Kanaho, Y. (2014) · Nature Communications · doi:10.1038/ncomms5744 · Cited by 31
Raasakka, A., Myllykoski, M., Laulumaa, S., Lehtimäki, M., Haertlein, M., Moulin, M., Kursula, I., & Kursula, P. (2015) · Scientific Reports · doi:10.1038/srep16520 · Cited by 32
ADAMTS‐4 in oligodendrocytes contributes to myelination with an impact on motor function
Pruvost, M., Lépine, M., Leonetti, C., Etard, O., Naveau, M., Agin, V., Docagne, F., Maubert, E., Ali, C., Emery, É., et al. (2017) · Glia · doi:10.1002/glia.23207 · Cited by 32
“The myelin sheath, produced by oligodendrocytes in the central nervous system (CNS) enables energy-efficient saltatory conduction and is necessary to maintain axonal integrity and survival (Lappe-siefke et al., 2003).”
BackgroundMultiple paradigm shifts in multiple sclerosis
Kieseier, B. C., & Hartung, H. (2003) · Current Opinion in Neurology · doi:10.1097/00019052-200306000-00001 · Cited by 31
Sullivan, J. M., Bagnell, A. M., Alevy, J., Avila, E. M., Mihaljević, L., Saavedra-Rivera, P. C., Kong, L., Huh, J. S., McCray, B. A., Aisenberg, W. H., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adk1358 · Cited by 29
Jackson, E. K., Menshikova, E. V., Mi, Z., Verrier, J. D., Bansal, R., Janesko‐Feldman, K. L., Jackson, T. C., & Kochanek, P. M. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015040397 · Cited by 29
Krestinina, O. V., Yulia, B., & Papadopoulos, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093217 · Cited by 29
Cellular basis of ClC-2 Cl− channel–related brain and testis pathologies
Göppner, C., Soria, A. H., Hoegg-Beiler, M. B., & Jentsch, T. J. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.016031 · Cited by 30
“The generation and validation of the following mouse models have been described as indicated: Clcn2 mice (14); Clcn2 mice (28); Glialcam mice (9); AMH-Cre mice (30); Stra8-Cre (31); Trp1-Cre (32); Cnp-cre (38); GFAP-Cre (39); GLAST-CreERT2 (40); Aldh1/1-CreERT2 (41).”
MethodCheng, A., Kawahata, K., & Fukunaga, K. (2020) · Biomedicines · doi:10.3390/biomedicines8120635 · Cited by 30
“Oligodendrocytes are myelinating glial cells in the central nervous system (CNS) that constitute about 5–10% of the total glial population, and are critical for rapid action potential propagation and metabolic support of neurons [1,2].”
BackgroundComparison of CNS and PNS myelin proteins in the pathology of myelin disorders
Quarles, R. H. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.10.005 · Cited by 30
“Surprisingly, however, the recently generated CNP-null mice appear to myelinate entirely normally, but exhibit axonal swelling and degeneration leading to premature death in adult life [22].”
BackgroundThe Mitochondrial m-AAA Protease Prevents Demyelination and Hair Greying
Wang, S., Jacquemyn, J., Murru, S., Martinelli, P., Barth, E., Langer, T., Niessen, C. M., & Rugarli, E. I. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006463 · Cited by 29
Ornelas, I. M., Khandker, L., Wahl, S., Hashimoto, H., Macklin, W. B., & Wood, T. L. (2020) · Glia · doi:10.1002/glia.23776 · Cited by 32
Costello, F., Klistorner, A. I., & Kardon, R. H. (2011) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/15428877-20110627-03 · Cited by 30
Limited TCF7L2 Expression in MS Lesions
Lürbke, A., Hagemeier, K., Cui, Q.-L., Metz, I., Brück, W., Antel, J., & Kuhlmann, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072822 · Cited by 28
“and lack of trophic support from myelin sheaths [7,8].”
BackgroundEvidence for glutamine synthetase function in mouse spinal cord oligodendrocytes
Haim, L. B., Schirmer, L., Zulji, A., Sabeur, K., Tiret, B., Ribon, M., Chang, S., Lamers, W. H., Boillée, S., Chaumeil, M. M., et al. (2021) · Glia · doi:10.1002/glia.24071 · Cited by 30
“CNP-cre transgenic mice (Lappe-Siefke et al., 2003) were commercially available (Jackson Lab).”
MethodMolecular and immunological origins of catatonia
Beach, S. R., Luccarelli, J., Praschan, N. C., Fusunyan, M. A., & Fricchione, G. L. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.03.013 · Cited by 31
2′,3′-Cyclic Nucleotide 3′-Phosphodiesterase
Braun, P. E., Gravel, M., & Lee, J. (2004) · Elsevier eBooks · doi:10.1016/b978-012439510-7/50072-3 · Cited by 30
Self-citationMultiple sclerosis pathogenesis: missing pieces of an old puzzle
Rahmanzadeh, R., Brück, W., Minagar, A., & Sahraian, M. A. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0002 · Cited by 29
Angelis, F. D., Connick, P., Parker, R. A., Plantone, D., Doshi, A., John, N. A., Stutters, J., MacManus, D. G., Prados, F., Marshall, I., et al. (2020) · Efficacy and Mechanism Evaluation · doi:10.3310/eme07030 · Cited by 28
Origin of axonal proteins: Is the axon‐schwann cell unit a functional syncytium?
López‐Leal, R., Álvarez, J., & Court, F. A. (2016) · Cytoskeleton · doi:10.1002/cm.21319 · Cited by 28
“In a cell specific oligodendrocyte Cnp Knockout, a non-structural protein component of myelin, axonal degeneration takes place without observable desmyelination, suggesting that oligodendrocytes support axonal survival through a myelin-independent mechanism [Lappe-Siefke et al., 2003].”
BackgroundOligodendrocytes: Development, Physiology and Glucose Metabolism
Amaral, A. I., Tavares, J. M., Sonnewald, U., & Kotter, M. (2016) · Advances in neurobiology · doi:10.1007/978-3-319-45096-4_10 · Cited by 31
CNP deficiency causes severe hypomyelinating leukodystrophy in humans
AlAbdi, L., Murshedi, F. A., Elmanzalawy, A., Habsi, A. A., Helaby, R., Ganesh, A., Ibrahim, N., Patel, N., & Alkuraya, F. S. (2020) · Human Genetics · doi:10.1007/s00439-020-02144-4 · Cited by 27
“1 3 in premature death before 1 year of age, and the observed axonal degeneration has been proposed to result from uncoupling of myelin assembly and axonal preservation as a result of CNP deficiency (Lappe-Siefke et al. 2003).”
BackgroundInfluentialEffects of experimental hypothyroidism on myelin sheath structural organization
Ferreira, A. A., Nazário, J. C., Pereira, M. J. D. S., AZEVEDO, N. L. D., & Barradas, P. C. (2004) · Journal of Neurocytology · doi:10.1023/b:neur.0000030697.78488.63 · Cited by 27
Huang, G. J., Li, Z., Liu, X., Guan, M., Zhou, S., Zhong, X., Zheng, T., Xin, D. E., Gu, X., Mu, D., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01754-9 · Cited by 30
“To examine the role of DOR in the maturation of premyelinating OLs, we conditionally deleted Dor by crossing the Dor fl/fl mice with Cnp-Cre mice in which Cre is expressed from the Cnp promoter in postmitotic iOLs or differentiating OLs 34,35 .”
Identification of Tmem10 as a Novel Late-stage Oligodendrocytes Marker for Detecting Hypomyelination
Jiang, W., Yang, W., Yang, W., Zhang, J., Pang, D., Gan, L., Luo, L., Fan, Y., Liu, Y., & Chen, M. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.7526 · Cited by 26
“Furthermore, CNP- and PLP-knockout mice show axonal degeneration [2, 4].”
BackgroundNeuroinflammation in white matter tracts of Cnp1 mutant mice amplified by a minor brain injury
Wieser, G. L., Gerwig, U. C., Adamcio, B., Barrette, B., Nave, K., Ehrenreich, H., & Goebbels, S. (2013) · Glia · doi:10.1002/glia.22480 · Cited by 25
“ground were generated previously by homologous recombination in embryonic stem cells (Lappe-Siefke et al., 2003).”
BackgroundMethodSelf-citationGrowth‐associated protein 43 in lesions and cerebrospinal fluid in multiple sclerosis
Teunissen, C. E., Dijkstra, C. D., Jasperse, B., Barkhof, F., Vanderstichele, H., Vanmechelen, E., Polman, C. H., & Bø, L. (2006) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00730.x · Cited by 30
Wootla, B., Đenić, A., Watzlawik, J. O., Warrington, A. E., & Rodriguez, M. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9436-3 · Cited by 27
“indicated that CNP is essential for oligodendroglial functions in axonal support and myelination [46].”
Multiple Sclerosis: Basic and Clinical
Buzzard, K. A., Chan, W. H., Kilpatrick, T. J., & Murray, S. S. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-57193-5_8 · Cited by 36
Emamnejad, R., Pagnin, M., & Petratos, S. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105788 · Cited by 30
Genetic influences on cortical myelination in the human brain
Liu, S., Li, A., Zhu, M., Li, J., & Liu, B. (2018) · Genes Brain & Behavior · doi:10.1111/gbb.12537 · Cited by 26
Wang, L., Yang, H., Zang, C., Dong, Y., Shang, J., Chen, J., Wang, Y., Liu, H., Zhang, Z., Xu, H., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104630 · Cited by 26
“Oligodendrocytes are well known as myelin-forming cells with crucial role in facilitating the rapid conduction of neuronal action potentials (Miller, 2005) and supporting axonal survival (Lappe-Siefke et al., 2003).”
BackgroundTranslatomic analysis of regenerating and degenerating spinal motor neurons in injury and ALS
Shadrach, J. L., Stansberry, W. M., Milen, A. M., Ives, R. E., Fogarty, E. A., Antonellis, A., & Pierchala, B. A. (2021) · iScience · doi:10.1016/j.isci.2021.102700 · Cited by 28
“, 2016) and the oligodendrocyte marker 2030-cyclicnucleotide 30phosphodiesterase (CNPase) (Lappe-Siefke et al., 2003) were not enriched (Figure 2F).”
BackgroundSteyer, A. M., Buscham, T. J., Lorenz, C., Hümmert, S., Eichel‐Vogel, M. A., Schadt, L. C., Edgar, J. M., Köster, S., Möbius, W., Nave, K., et al. (2022) · Glia · doi:10.1002/glia.24290 · Cited by 25
“ously reported (Klugmann et al., 1997; Lappe-Siefke et al., 2003; Montag et al., 1994; Patzig, Erwig, et al., 2016) and maintained on a c57Bl/6 N background for at least 10 generations.”
BackgroundSelf-citationAlanko, V., Gaminde‐Blasco, A., Quintela‐López, T., Loera‐Valencia, R., Solomon, A., Björkhem, I., Cedazo-Mínguez, Á., Maioli, S., Tabacaru, G., Latorre‐Leal, M., et al. (2023) · Glia · doi:10.1002/glia.24348 · Cited by 26
“MBP is not only affecting myelin compaction (Snaidero et al., 2017) but it is also one of the rate-limiting myelin formation factors together with e.g. cholesterol and CNPase (Lappe-Siefke et al., 2003; Popko et al., 1987; Saher et al., 2005).”
BackgroundGregorio, I. D., Russo, L., Torretta, E., Barbacini, P., Contarini, G., Pacinelli, G., Bizzotto, D., Moriggi, M., Braghetta, P., Papaleo, F., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00713-z · Cited by 27
“The Cnp1-cre mouse line [37] was crossed with a line bearing loxP sequences flanking Gba1 exons 9–11 [36], producing a mouse line with deletion of the exons encoding for β-glucocerebrosidase catalytic domain in oligodendrocytes (and Schwann cells), namely Gba1 f/f ::Cnp1 Wt/cre (hereafter and in…”
BackgroundMethodStimulating myelin restoration with BDNF: a promising therapeutic approach for Alzheimer's disease
Zota, I., Chanoumidou, K., Gravanis, A., & Charalampopoulos, I. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1422130 · Cited by 25
Neural stem cells restore myelin in a demyelinating model of Pelizaeus-Merzbacher disease
Gruenenfelder, F. I., McLaughlin, M., Griffiths, I. R., Garbern, J. Y., Thomson, G., Kuzman, P., Barrie, J. A., McCulloch, M. C., Penderis, J., Stassart, R. M., et al. (2020) · Brain · doi:10.1093/brain/awaa080 · Cited by 27
“…reduced levels of CNP could potentially interfere with trafficking between the glial cell body and the glia-axonal junction, resulting in impaired metabolic support of axons (Saab et al., 2013; Stassart et al., 2018) and secondary axon degeneration (Lappe-Siefke et al., 2003; Edgar et al., 2009).”
BackgroundSelf-citationWang, S., Wang, T., Tao, L., Xie, R., Zhao, X., Wang, L., Yang, Q., Jia, L., & Han, J. (2020) · Glia · doi:10.1002/glia.23838 · Cited by 25
“CNPase knockout disrupts the formation of the inner tongue of oligodendrocyte processes that myelinate small-diameter axons, and it promotes postnatal axonal degeneration (Edgar et al., 2009; Lappe-Siefke et al., 2003).”
BackgroundEdgar, J. M., & Griffiths, I. R. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374709-9.00005-5 · Cited by 29
Self-citationMice lacking Plexin-B3 display normal CNS morphology and behaviour
Worzfeld, T., Rauch, P. J., Karram, K., Trotter, J., Kuner, R., & Offermanns, S. (2009) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.08.008 · Cited by 28
Axon Myelin Transfer of a Non-Enveloped Virus
Roussarie, J.-P., Ruffié, C., Edgar, J. M., Griffiths, I. R., & Brahic, M. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001331 · Cited by 25
“For example, inactivating the Cnp1 myelin gene does not alter myelin ultrastructure but causes accumulation of membranous organelles in the axons, axon swelling and degeneration [2].”
BackgroundSelf-citationChanges at the nodal and perinodal axonal domains: a basis for multiple sclerosis pathology?
Desmazières, A., Sol-Foulon, N., & Lubetzki, C. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458511434370 · Cited by 24
Nonvesicular lipid transfer drives myelin growth in the central nervous system
Wu, J., Kislinger, G., Duschek, J., Durmaz, A. D., Wefers, B., Feng, R., Nalbach, K., Wurst, W., Behrends, C., Schifferer, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53511-y · Cited by 28
Yin, X., Kidd, G. J., Nave, K., & Trapp, B. D. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0771-08.2008 · Cited by 24
“Mice null for MAG (Yin et al., 1998) or CNP (Lappe-Siefke et al., 2003) myelinate normally but have primary axonal phenotypes that result in axonal degeneration.”
Self-citationRao, R. C., Boyd, J. D., Padmanabhan, R., Chenoweth, J. G., & McKay, R. D. G. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0205 · Cited by 24
Meyer, L., Patte‐Mensah, C., Taleb, O., & Mensah‐Nyagan, A. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080915 · Cited by 24
“(CNPase) that is pivotal for axonal survival [43,44].”
BackgroundRemyelinating strategies in multiple sclerosis
Luessi, F., Kuhlmann, T., & Zipp, F. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.969241 · Cited by 25
“Furthermore, it was demonstrated that the function of glia in supporting axonal integrity can be uncoupled from its function in maintaining compact myelin [42], the latter being required to facilitate the fast conduction of nerve impulses throughout the nervous system [43].”
BackgroundNeuroprotective strategies in MS: Lessons from C57BL/WldS mice
Coleman, M. P., Adalbert, R., & Beirowski, B. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.03.028 · Cited by 27
“[14], myelin defects [3,30], traumatic brain injury [9], amyotrophic lateral sclerosis (ALS) [25,42,53], HIV dementia [2,48], tauopathies [32,47], Creutzfeld–Jakob disease [33], gad [41] and hereditary spastic paraplegia [17].”
BackgroundPrecision therapies for genetic epilepsies in 2025: Promises and pitfalls
Wang, S., Perucca, E., Berkovic, S. F., & Perucca, P. (2025) · Epilepsia Open · doi:10.1002/epi4.70065 · Cited by 25
Guzman, K., Brink, L. E., Bey, G. R., Bodnar, R. J., Kuang, L., Xing, B., Sullivan, M. L. G., Park, H. J., Koppes, E., Zhu, H., et al. (2020) · Glia · doi:10.1002/glia.23825 · Cited by 24
Eukaryotic tRNA splicing – one goal, two strategies, many players
Gerber, J. L., Köhler, S., & Peschek, J. (2022) · Biological Chemistry · doi:10.1515/hsz-2021-0402 · Cited by 23
Olig2Ablation in Immature Oligodendrocytes Does Not Enhance CNS Myelination and Remyelination
Wang, J., Yang, L., Jiang, M., Zhao, C., Liu, X., Berry, K., Waisman, A., Langseth, A. J., Novitch, B. G., Bergles, D. E., et al. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.0237-22.2022 · Cited by 23
Autophagy collaborates with apoptosis pathways to control oligodendrocyte number
Zhang, T., Bhambri, A., Zhang, Y., Barbosa, D., Bae, H., Xue, J., Wazir, S., Mulinyawe, S. B., Kim, J. H., & Sun, L. O. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112943 · Cited by 25
Akinlaja, Y. O., & Nishiyama, A. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1418100 · Cited by 25
The Polarity Protein Pals1 Regulates Radial Sorting of Axons
Zollinger, D. R., Chang, K.-J., Baalman, K. L., Kim, S., & Rasband, M. N. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.1593-15.2015 · Cited by 24
“…et al., 2010), with mice expressing Cre recombinase under the control of the 2 , 3 -cyclic nucleotide phosphodiesterase (CNP) promoter (CNPcre/ ) (Lappe-Siefke et al., 2003); hereafter the conditional knock-out mice lacking Pals1 in myelinating glia will be referred to as CNPcre/ ;Pals1fl/fl or…”
BackgroundMethodInfluentialCentral nervous system regeneration--where are we?
Williams, A. (2013) · QJM · doi:10.1093/qjmed/hct260 · Cited by 26
Luo, F., Zhang, J., Burke, K., Romito‐DiGiacomo, R. R., Miller, R. H., & Yang, Y. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.05.001 · Cited by 23
A novel myelin protein zero transgenic zebrafish designed for rapid readout of in vivo myelination
Preston, M., Finseth, L. T., Bourne, J. N., & Macklin, W. B. (2019) · Glia · doi:10.1002/glia.23559 · Cited by 24
“…(CNP) alters myelin, leading to axon swelling and degeneration in animals as they age (Anderson et al., 1998; Griffiths et al., 1998; Lappe-Siefke et al., 2003; Rasband et al., 2005; Uschkureit, Sporkel, Stracke, Büssow, & Stoffel, 2000), which suggests that the long-term health of…”
Oligodendrocyte-specific ATF4 inactivation does not influence the development of EAE
Yue, Y., Stanojlović, M., Lin, Y., Karsenty, G., & Lin, W. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1415-6 · Cited by 24
Genetically induced brain inflammation by Cnp deletion transiently benefits from microglia depletion
Garcia‐Agudo, L. F., Jáňová, H., Sendler, L. E., Arinrad, S., Steixner, A. A., Hassouna, I. A., Balmuth, E. A., Ronnenberg, A., Schopf, N., van der Flier, F. J., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201900337r · Cited by 26
“Genotyping was previouslydescribed (2, 3).”
BackgroundSelf-citationArinrad, S., Wilke, J. B. H., Seelbach, A., Doeren, J., Hindermann, M., Butt, U. J., Steixner-Kumar, A. A., Spieth, L., Ronnenberg, A., Pan, H., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01392-8 · Cited by 24
“of progressive, genetically induced white matter inflammation [43], were immunized at the age of 8 weeks with a cocktail of four GluN1 extracellular peptides (GluN135-53, GluN1361-376, GluN1385399, and GluN1660-811) [9, 24], including a peptide in the N-terminal domain containing the G7 epitope (N368/G369) [45], versu…”
BackgroundMethodSelf-citation
Metadata
- Authors
- Lappe-Siefke, C., Goebbels, S., Gravel, M., Nicksch, E., Lee, J., Braun, P. E., Griffiths, I. R., & Nave, K.-A.
- Affiliations
- Max Planck Institute of Experimental Medicine (DE)
- Max Planck Society (DE)
- McGill University (CA)
- University of Glasgow (GB)
- Corresponding author
- Nave, Klaus-Armin
- Venue
- Nature Genetics
- Published
- 2003-02-18
- Volume
- 33
- Issue
- 3
- Pages
- 366-374
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2000485285
- Cited by
- 1,036
- References
- 52
- Citations by year
- 2026: 28 · 2025: 38 · 2024: 46 · 2023: 51 · 2022: 38 · 2021: 40 · 2020: 48 · 2019: 52 · 2018: 48 · 2017: 53 · 2016: 44 · 2015: 57 · 2014: 56 · 2013: 49 · 2012: 51
- FWCI
- 24.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- Cnp1, cyclic nucleotide phosphodiesterase, oligodendrocytes, myelination, axonal swellings, neurodegeneration, hydrocephalus, myelin ultrastructure, axonal integrity, multiple sclerosis
- MeSH terms
- Animals, Axons, Cytoskeleton, Female, Heterozygote, Homozygote, Male, Mice, Inbred C57BL, Myelin Sheath, Nerve Degeneration, Oligodendroglia, Phenotype, 2',3'-Cyclic-Nucleotide Phosphodiesterases, Mice, Knockout, Gene Targeting, Heredodegenerative Disorders, Nervous System, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.